CapecitabineMyelosuppression and impaired liver function: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1771卷 / 1期

关键词：

D O I：

10.1007/s40278-019-67896-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：77 / 77

相关论文

共 50 条

[1] Fluorouracil/gemcitabineLeukocytopenia, impaired liver function and anorexia: 6 case reports
Reactions Weekly, 2016, 1596 (1) : 96 - 96
[2] FebuxostatAbnormal liver function: 2 case reports
Reactions Weekly, 2018, 1729 (1) : 122 - 122
[3] MethotrexateElevation of liver function tests: 2 case reports
Reactions Weekly, 2018, 1705 (1) : 202 - 202
[4] CabozantinibElevated liver function tests: 2 case reports
Reactions Weekly, 2020, 1815 (1) : 85 - 85
[5] MethotrexateElevated liver function tests: 2 case reports
Reactions Weekly, 2018, 1691 (1) : 185 - 185
[6] ImatinibNeutropenia, febrile neutropenia, impaired liver function and skin eruption: 4 case reports
Reactions Weekly, 2015, 1578 (1) : 163 - 163
[7] AlmitrineHepatic cytolysis and acute impaired hepatic function: 2 case reports
Reactions Weekly, 2020, 1794 (1) : 20 - 20
[8] RofecoxibKidney disorders in patients with impaired renal function: 2 case reports
Reactions Weekly, 2001, 882 (1) : 11 - 11
[9] PosaconazoleAbnormal liver function, nausea and vomiting: 2 case reports
Reactions Weekly, 2017, 1663 (1) : 251 - 251
[10] UstekinumabFatty liver infiltration and elevated liver function tests: 2 case reports
Reactions Weekly, 2017, 1681 (1) : 346 - 346

← 1 2 3 4 5 →